RegenerationPeptides6 min read
Peptide Combinations in Research: TB-500 and BPC-157 as Synergists
TB-500 and BPC-157 are frequently used in combination in research laboratories. What science knows about their complementary mechanisms.
Fat MetabolismPeptides
HGH Fragment 176-191: Current Insights into Lipolytic Signal Transduction
5 min read
HGH Fragment 176-191: The State of Lipolysis Research
HGH Fragment 176-191 (AOD9604) was originally characterised as the lipolytic sub-molecule of growth hormone. More than two decades after the first preclinical studies by Heffernan et al., the peptide remains an important research object for scientists investigating the molecular basis of GH-mediated lipolysis.
Molecular Mechanism: Not via the GH Receptor
The decisive mechanistic finding is that HGH Fragment 176-191 does not mediate lipolysis via the classical growth hormone receptor (GHR). While full GH binds to GHR and signals via JAK2/STAT5, the fragment activates other signalling pathways — possibly beta-3-adrenergic receptors (beta-3-AR) in adipose tissue.
Beta-3-adrenergic receptors are primarily expressed in brown and white adipose tissue. They stimulate thermogenic and lipolytic processes — a mechanism also used by other lipolytic research compounds.- 💡 Note
Consequences of the GHR-Independent Mechanism
- No increase in IGF-1 (no growth-promoting effect)
- No induction of insulin resistance (classic GH side effect)
- No acromegaly risks with long-term exposure
- Potentially tissue-specific lipolysis without systemic GH effects
Why Did the Phase 3 Study Fail?
Metabolic Pharmaceuticals (now Calzada) conducted Phase 3 studies with AOD9604 in 900 obese participants between 2004 and 2007. Despite positive Phase 1/2 data, Phase 3 showed no significant superiority over placebo on the primary endpoint of body weight reduction. Possible explanations include cohort heterogeneity and insufficient dose-finding.
Current Research Applications
Regardless of its clinical development fate, HGH Fragment 176-191 remains a valuable tool for fundamental research on lipolytic signalling pathways, beta-3-AR pharmacology and GH biology. For research laboratories, Studien Peptide provides the peptide as a high-purity lyophilisate.
